These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 401112)
41. Effect of local immunotherapy of syngeneic rat fibrosarcoma with hapten and antihapten-tumor serum upon nonlocally treated tumor. Arai K; Wallace HW Cancer Res; 1979 Sep; 39(9):3638-43. PubMed ID: 314334 [No Abstract] [Full Text] [Related]
42. Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma. Arai K; Spencer JS; Sohn M; Wallace HW Cancer Res; 1979 Jan; 39(1):6-16. PubMed ID: 310708 [No Abstract] [Full Text] [Related]
43. [Future perspectives on tumor-specific immunotherapy using hapten-reactive T cell activity]. Hamaoka T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):886-96. PubMed ID: 2786376 [TBL] [Abstract][Full Text] [Related]
44. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system. Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375 [TBL] [Abstract][Full Text] [Related]
45. Effect of anti-hapten serum on hapten-treated rat tumor. Wallace HW; Arai K Surg Forum; 1978; 29():126-8. PubMed ID: 401112 [No Abstract] [Full Text] [Related]
46. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma. Hillman GG; Droz JP; Haas GP In Vivo; 1994; 8(1):77-80. PubMed ID: 8054515 [TBL] [Abstract][Full Text] [Related]